Amantadine monotherapy of chronic hepatitis C patients infected with genotype 1b
Tarih
2000Yazar
Badur, S
Basaran, Gülcan
Turkoglu, S
Ozbay, Gülşen
Tabak, F
Senturk, H
Mert, A
Akdogan, M
Üst veri
Tüm öğe kaydını gösterÖzet
We aimed to test the efficacy of amantadine in chronic hepatitis C (CHC) patients infected with genotype Ib. Twenty patients completed treatment with amantadine HCl, 100 mg b.i.d., for 6 months. Non-sustained biochemical improvement was observed without loss of HCV-RNA, We conclude that amantadine monotherapy is not effective in CHC.
Koleksiyonlar
- Makale [92796]
